Clinical Studies for Lympha Press®

Clinicians > Clinical Studies

Clinical Studies

For over forty years, Lympha Press dynamic compression therapy systems have helped patients all over the world deal with lymphedema, chronic venous insufficiency, wounds, and lipedema. We’re the number one global brand in pneumatic compression for many reasons, including proven clinical evidence in over thirty peer-reviewed publications.

Addition of Intermittent Pneumatic Compression to Conventional Treatment Improves Volume Reduction Before Lymphatic Surgery for Lower Limb Lymphedema: A Pilot Study

C C Campisi, E Parodi, A Demoro, R Risso, W D Brinda, C Campisi; Lymphology 2023

This study evaluates the impact of adding intermittent pneumatic compression (IPC) to complete decongestive therapy (CDT) for reducing limb volume in lower limb lymphedema patients before lymphatic surgery.

Addressing Lymphedema in the Severely Overweight with an Innovative Pneumatic Compression Therapy: A Pilot Study

L. VanHoose, S. Kanaan, E. Haynes, T. Messer. Originally presented at the XVII World Meeting of the International Union of Phlebology, September 2013. University of Kansas Medical Center, Kansas City, KS.

This study’s objective was identification of additive benefits of a novel pneumatic compression therapy, the LymphaPod® (Lympha Press®, Glen Mills, PA), to a conventional therapy plan for the treatment of lower extremity lymphedema and associated impairments in the severely overweight.

Advanced Pneumatic Compression for Treatment of Breast Cancer-Related Lymphedema of the Thorax

Karen Ashforth, MS, OTR, CLT-LANA. January 2022. Saint Joseph’s Medical Center, Stockton, California.

In this case series, three breast cancer-related lymphedema patients with significant thoracic pain, swelling, and fibrosis displayed a significant decrease in arm and thoracic swelling after using intermittent pneumatic therapy at home. Treatment occurred over a subsequent 3-4 week period with a Lympha Press half jacket that treated the thorax with direct compression via a dedicated axillary chamber. Final measurements show a carryover of decongestion for up to three days following Lympha Press treatment, as well as reduced pain symptoms.

The Role of Intermittent Pneumatic Compression in the Treatment of Lower Extremity Chronic Wounds

Surgical Technology International, 2021

This study investigates the effect of intermittent pneumatic compression on a subset of patients with lower extremity wounds associated with venous and/or lymphatic disease, the combination often referred to as “lymphoplebitic” disease.

Promoting a Multidisciplinary Approach to Treating Chronic Edema

Vein Magazine, 2020

The purpose of this paper is to reflect on the three states of lymphatic treatment and the importance of taking a multidisciplinary approach to edema management.

The use of a Peripheral Calibrated Gradient Compression Pump for the Treatment of Chronic Venous Leg Ulcers

Patel M, Pesek E, Lantis JC II. Presented at Symposium on Advanced Wound Care, Spring, May 2019, San Antonio TX USA.

Patients with chronic venous stasis ulcers were treated with Lympha Press® PCD-51™ and multilayer bandaging, at home for eight weeks. All five patients were compliant with the treatment and showed reduction of edema, reduced wound size, odor, pain, and exudate. Four of the five patients had complete wound healing.

12 3 4 5

Lympha Press has been great to work with. My patients have been consistently happy with their pumps. I have seen greatly improved quality of life for patients who are able to walk easier and their wounds have improved with their lymphedema pump.

Wendy McKee, RN

Wooster Community Hospital Wound Healing Center, Wooster, OH

It is amazing the difference in swelling after our patients start using the lymphedema pumps. Lympha Press is wonderful to work with.

Barb A.

Wound Care Advantage, Alliance, OH